Many experts expect immunotherapy to positively impact the treatment landscape for patients with earlier-stage cancers in the neoadjuvant, adjuvant, and perioperative settings, according to a new...
Moderna and the Institute for Life Changing Medicines (ILCM) recently collaborated to develop a new mRNA therapeutic (mRNA-3351) for ultra-rare disease, Crigler-Najjar Syndrome Type 1...
Eli Lilly and Company recently announced that its prescription medicine, Jardiance, elicited a 21-percent relative risk reduction in death or hospitalization for heart failure patients compared to...
Thermo Fisher Scientific and AstraZeneca recently entered into a global, multiyear partnership to co-develop next-generation sequencing (NGS)-based companion diagnostics (CDx) for targeted...
Black Americans are still significantly underrepresented in cardiovascular disease clinical trials, and enrollment rates have not improved over time, according to a new paper published in the Journal...
Eli Lilly and Company recently entered into a multi-year research collaboration and licensing agreement with Lycia Therapeutics to discover, deliver, and commercialize novel targeted drug...
Bristol Myers Squibb recently announced that FDA accepted a supplemental biologics license application for its Acute Graft Versus Host Disease (aGvHD) therapy, Orencia.
Orencia is intended to...
FDA recently granted accelerated approval to GSK’s PD-1 blocking antibody drug, Jemperli, for adult patients with mismatch repair-deficient (dMMR) recurrent or advanced solid...
FDA recently approved Abbott’s device to treat individuals with atrial fibrillation (AFib) at risk of ischemic stroke.
The Amplatzer Amulet Left Atrial Appendage Occluder immediately closes the...
Moderna recently announced that the first patient has received a dose in a Phase 1/2 study of its mRNA therapeutic, mRNA-3705, for methylmalonic acidemia (MMA).
The open-label landmark study...
FDA recently granted emergency use authorization for Thermo Fisher Scientific’s two PCR-based COVID-19 test kits.
The test kits, TaqPath COVID-19 Fast PCR Combo Kit 2.0 and TaqPath COVID-19...
The novel FDA drug approval process allows researchers to uncover the appropriate dosage for both children and adults, determine the best route of administration, and test for any drug interactions....
Kite and Appia Bio recently collaborated to research and develop HSC-derived allogeneic cell therapies for cancers.
Under the collaboration, the companies will develop chimeric antigen receptor...
Moderna recently announced that FDA granted Fast Track designation for its mRNA respiratory syncytial virus (RSV) vaccine, mRNA-1345, for use in adults 60 years of age and older.
FDA Fast Track...
Over half of retail pharmacy customers (51 percent) have used health and wellness services over the past year, according to the J.D. Powers 2021 US Pharmacy Study.
This number is up from...
FDA recently approved GSK’s Nucala, a monoclonal antibody that targets interleukin-5, as a treatment for patients with chronic rhinosinusitis with nasal polyps (CRSwNP).
The new indication for...
FDA recently updated the emergency use authorization for Regeneron’s investigational COVID-19 antibody cocktail, REGEN-COV.
The authorization now includes post-exposure prophylaxis in...
Eli Lilly and Company and Kumquat Biosciences recently entered into a multi-year collaboration to discover, develop, and commercialize potential small molecule drug candidates that stimulate...
AstraZeneca recently entered into a collaboration with Regeneron to research, develop, and commercialize small molecule drug candidates to treat obesity and related co-morbidities.
Specifically,...
The Department of Defense (DoD) recently awarded a $6 million technology and therapeutic development award to the University of Illinois (UIC) to test a COVID-19 drug candidate.
UIC will use the...
